‘‘(2) collect and disseminate protocols and evi-
dence-based practices regarding pain and palliative 
care, including pain care for terminally ill patients, 
and make such information available to Federal, 
State, and local regulatory and enforcement agen-
cies, public and private health care programs, payors 
and providers, health professions schools, hospices, 
and the general public. 
‘‘(b) DEFINITIONS.—For purposes of this section: 
‘‘(1) The term ‘palliative care’ means the com-
prehensive active, total care of patients whose dis-
ease or medical condition is not responsive to cura-
tive treatment or whose prognosis is limited due to 
progressive, far-advanced disease. Palliative care in-
cludes treatment to reduce or alleviate pain and 
other distressing signs and symptoms. The purpose 
of such care is to eliminate, alleviate, or manage the 
patient’s pain and suffering and thereby enhance the 
quality of life. 
‘‘(2) The term ‘pain care’ means the evaluation, 
diagnosis, treatment, and management of primary 
and secondary pain, whether acute, chronic, per-
sistent, intractable, or associated with the end of 
life.’’.
(b) EDUCATION AND TRAINING IN PAIN AND PALLIA-
TIVE CARE.—Part D of title VII of the Public Health 
Service Act (42 U.S.C. 294 et seq.) is amended—
(1) by redesignating sections 754 through 757 
as sections 755 through 758, respectively; and 
(2) by inserting after section 753 the following: 
‘‘SEC. 754. PROGRAM FOR EDUCATION AND TRAINING IN 
PAIN AND PALLIATIVE CARE. 
‘‘(a) IN GENERAL.—The Secretary, in consultation 
with the Director of the Agency for Healthcare Research 
and Quality, may make awards of grants, cooperative 
agreements, and contracts to health professions schools, 
hospices, and other public and private entities for the de-
velopment and implementation of programs to provide 
education and training to health care professionals in pain 
and palliative care. 
‘‘(b) PRIORITIES.—In making awards under sub-
section (a), the Secretary shall give priority to awards for 
the implementation of programs under such subsection. 
‘‘(c) CERTAIN TOPICS.—An award may be made 
under subsection (a) only if the applicant for the award 
agrees that the program carried out with the award will 
include information and education on—
‘‘(1) professionally recognized means for diag-
nosing and treating pain and related signs and
symptoms, including the medically appropriate use 
of controlled substances; 
‘‘(2) applicable laws on controlled substances, 
including the degree to which misconceptions con-
cerning such laws or the enforcement thereof may 
create barriers to patient access to appropriate and 
effective pain care; 
‘‘(3) comprehensive interdisciplinary approaches 
to the delivery of pain and palliative care, including 
delivery through specialized centers of pain care 
treatment expertise; and 
‘‘(4) recent findings, developments, and im-
provements in the provision of pain and palliative 
care. 
‘‘(d) PROGRAM
SITES.—Education and training 
under subsection (a) may be provided at or through health 
professions schools, residency training programs, and 
other graduate programs in the health professions, entities 
that provide continuing medical and pharmacy education, 
hospices, and such other programs or sites as the Sec-
retary determines to be appropriate. 
‘‘(e) EVALUATION
OF PROGRAMS.—The Secretary 
shall (directly or through grants or contracts) provide for 
the evaluation of programs implemented under subsection
(a) in order to determine the effect of such programs on 
knowledge and practice regarding pain and palliative care. 
‘‘(f) PEER REVIEW GROUPS.—In carrying out section 
799(f) with respect to this section, the Secretary shall en-
sure that the membership of each peer review group in-
volved includes individuals with expertise and experience 
in pain and palliative care. 
‘‘(g) DEFINITIONS.—For purposes of this section: 
‘‘(1) The term ‘palliative care’ means the com-
prehensive active, total care of patients whose dis-
ease or medical condition is not responsive to cura-
tive treatment or whose prognosis is limited due to 
progressive, far-advanced disease. Palliative care in-
cludes treatment to reduce or alleviate pain and 
other distressing signs and symptoms. The purpose 
of such care is to eliminate, alleviate, or manage the 
patient’s pain and suffering and thereby enhance the 
quality of life. 
‘‘(2) The term ‘pain care’ means the evaluation, 
diagnosis, treatment, and management of primary 
and secondary pain, whether acute, chronic, per-
sistent, intractable, or associated with the end of 
life.’’. 
(c) AUTHORIZATION OF APPROPRIATIONS.—Section 
758 of the Public Health Service Act (as redesignated by
subsection (a)(1) of this section) is amended in subsection 
(b)(1)(C)—
(1) by striking ‘‘sections 753, 754, and 755’’ 
and inserting ‘‘section 753, 754, 755, and 756’’; and 
(2) by striking ‘‘$22,631,000’’ and inserting 
‘‘$37,631,000’’. 
(d) TECHNICAL AMENDMENT.—Paragraph (2) of 
section 757(b) of the Public Health Service Act (as redes-
ignated by subsection (a)(1)) is amended by striking 
‘‘754(3)(A), and 755(b)’’ and inserting ‘‘755(3)(A), and 
756(b)’’. 
SEC. 5. PUBLIC AWARENESS CAMPAIGN ON PAIN MANAGE-
MENT. 
Part B of title II of the Public Health Service Act 
(42 U.S.C. 238 et seq.) is amended by adding at the end 
the following: 
‘‘NATIONAL EDUCATION OUTREACH AND AWARENESS 
CAMPAIGN ON PAIN MANAGEMENT 
‘‘SEC. 249. (a) ESTABLISHMENT.—Not later than 
June 30, 2004, the Secretary shall establish and imple-
ment a national education outreach and awareness cam-
paign described in subsection (b) to provide information 
to the public on responsible pain management, related 
symptom management, and palliative care. 
‘‘(b) REQUIREMENTS.—The Secretary shall design 
the public awareness campaign under this section to edu-
cate consumers, patients, their families, and other care-
givers with respect to—
‘‘(1) the incidence and importance of pain as a 
national public health problem; 
‘‘(2) the adverse physical, psychological, and fi-
nancial consequences that can result if pain is not 
appropriately diagnosed or treated; 
‘‘(3) the availability, benefits, and risks of all 
pain management and palliative care treatment op-
tions; 
‘‘(4) the right of patients to have their pain 
promptly assessed, appropriately treated, and regu-
larly reassessed, and to have their treatment ad-
justed if needed; 
‘‘(5) the availability in the public, non-profit, 
and private sectors of pain management-related in-
formation, services and resources for consumers, pa-
tients, their families, and other caregivers, including 
information on—
‘‘(i) appropriate assessment, diagnosis 
and treatment options for all types of pain 
and pain-related symptoms; and 
‘‘(ii) conditions for which no widely 
accepted treatment options are yet avail-
able; and